US13057Q3056 - Common Stock

We assign a fundamental rating of **5** out of 10 to **CRC**. **CRC** was compared to 207 industry peers in the **Oil, Gas & Consumable Fuels** industry. **CRC** has an average financial health and profitability rating. **CRC** has a valuation in line with the averages, but it does not seem to be growing.

In the past year **CRC** had a positive cash flow from operations.

With a **Return On Assets** value of **3.65%**, **CRC** perfoms like the industry average, outperforming **40.10%** of the companies in the same industry.

With a **Return On Equity** value of **7.99%**, **CRC** is not doing good in the industry: **60.87%** of the companies in the same industry are doing better.

The 3 year average ROIC (**13.15%**) for **CRC** is well above the current ROIC(**5.72%**). The reason for the recent decline needs to be investigated.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 3.65% | ||

ROE | 7.99% | ||

ROIC | 5.72% |

ROA(3y)14.41%

ROA(5y)20.81%

ROE(3y)29.93%

ROE(5y)N/A

ROIC(3y)13.15%

ROIC(5y)N/A

Looking at the **Profit Margin**, with a value of **7.61%**, **CRC** is doing worse than **60.39%** of the companies in the same industry.

In the last couple of years the **Profit Margin** of **CRC** has grown nicely.

Looking at the **Gross Margin**, with a value of **66.85%**, **CRC** is in the better half of the industry, outperforming **72.95%** of the companies in the same industry.

In the last couple of years the **Gross Margin** of **CRC** has remained more or less at the same level.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 14.35% | ||

PM (TTM) | 7.61% | ||

GM | 66.85% |

OM growth 3YN/A

OM growth 5Y2.07%

PM growth 3Y-44.95%

PM growth 5Y13.96%

GM growth 3Y5.65%

GM growth 5Y0.12%

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so **CRC** is still creating some value.

Compared to 5 years ago, **CRC** has more shares outstanding

An Altman-Z score of **2.44** indicates that **CRC** is not a great score, but indicates only limited risk for bankruptcy at the moment.

The **Debt to FCF ratio** of **CRC** (**5.00**) is better than **63.77%** of its industry peers.

A Debt/Equity ratio of **0.57** indicates that **CRC** is somewhat dependend on debt financing.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.57 | ||

Debt/FCF | 5 | ||

Altman-Z | 2.44 |

ROIC/WACC0.7

WACC8.15%

A Quick Ratio of **2.33** indicates that **CRC** has no problem at all paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 2.43 | ||

Quick Ratio | 2.33 |

The **Earnings Per Share** has been growing by **32.95%** on average over the past years. This is a very strong growth

The Revenue for **CRC** has decreased by **-37.05%** in the past year. This is quite bad

The **Revenue** has been decreasing by **-1.78%** on average over the past years.

EPS 1Y (TTM)-43.59%

EPS 3Y-41.55%

EPS 5Y32.95%

EPS Q2Q%13.21%

Revenue 1Y (TTM)-37.05%

Revenue growth 3Y21.57%

Revenue growth 5Y-1.78%

Sales Q2Q%-13.03%

Based on estimates for the next years, **CRC** will show a very negative growth in **Earnings Per Share**. The EPS will decrease by **-16.83%** on average per year.

EPS Next Y-1.35%

EPS Next 2Y-0.73%

EPS Next 3Y-16.83%

EPS Next 5YN/A

Revenue Next Year11.39%

Revenue Next 2Y17.57%

Revenue Next 3Y7.07%

Revenue Next 5YN/A

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

The rest of the industry has a similar **Price/Earnings** ratio as **CRC**.

Compared to an average S&P500 **Price/Earnings** ratio of **29.02**, **CRC** is valued a bit cheaper.

With a **Price/Forward Earnings** ratio of **10.02**, the valuation of **CRC** can be described as very reasonable.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 15.29 | ||

Fwd PE | 10.02 |

Compared to the rest of the industry, the **Price/Free Cash Flow** ratio of **CRC** is on the same level as its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 19.48 | ||

EV/EBITDA | 8.59 |

A cheap valuation may be justified as **CRC**'s earnings are expected to decrease with **-16.83%** in the coming years.

PEG (NY)N/A

PEG (5Y)0.46

EPS Next 2Y-0.73%

EPS Next 3Y-16.83%

Compared to an average industry **Dividend Yield** of **6.23**, **CRC** has a dividend in line with its industry peers.

Compared to an average S&P500 **Dividend Yield** of **2.33**, **CRC** pays a bit more dividend than the S&P500 average.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 3.19% |

Dividend Growth(5Y)N/A

Div Incr Years2

Div Non Decr Years2

DP51.22%

EPS Next 2Y-0.73%

EPS Next 3Y-16.83%

**CALIFORNIA RESOURCES CORP**

NYSE:CRC (8/15/2024, 3:15:00 PM)

After market: 50.46 0 (0%)**50.46**

**+1.5 (+3.06%) **

Chartmill FA Rating

GICS SectorEnergy

GICS IndustryGroupEnergy

GICS IndustryOil, Gas & Consumable Fuels

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap4.52B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 3.19% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 15.29 | ||

Fwd PE | 10.02 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)0.46

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 3.65% | ||

ROE | 7.99% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 14.35% | ||

PM (TTM) | 7.61% | ||

GM | 66.85% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.48

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.57 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 2.43 | ||

Quick Ratio | 2.33 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-43.59%

EPS 3Y-41.55%

EPS 5Y

EPS Q2Q%

EPS Next Y-1.35%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-37.05%

Revenue growth 3Y21.57%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y